Japan stock market week to July 2, 2007
9 July 2007
Japan stock market week to June 4, 2007
11 June 2007
GSK: new data will support Avandia safety
4 June 2007
Japan stock market week to May 14, 2007
21 May 2007
Japan stock market week to April 30, 2007
7 May 2007
Japan stock market week to April 16, 2007
23 April 2007
Lilly's 1st-qtr 2007 earnings drop 39%
23 April 2007
Japan stock market week to April 2, 2007
9 April 2007
Japan stock market week to March 19, 2007
26 March 2007
Japan stock market week to Feb 5, 2007
12 February 2007
Takeda's Tandemact approved by EMEA
29 January 2007
Canada: new formulary for new year - Ontario introducing reform
15 January 2007
Japan stock market week to Nov 20, 2006
27 November 2006
Takeda's Actos combats diabetic atherosclerosis
20 November 2006
Takeda's six-month profit drops 12.2%
13 November 2006
Japan stock market week to Nov 6, 2006
13 November 2006
Japan stock market week to Oct 30, 2006
6 November 2006
Japan stock market week to Oct 23, 2006
30 October 2006
Lilly's 3rd-qtr 2006 profit rises 10% on Zyprexa
30 October 2006
Takeda's Competact launched in the UK
16 October 2006
Takeda gets attorney's fees in Actos patent case
2 October 2006
Takeda's Actos yields positive CV effects in diabetics
25 September 2006
Japan stock market week to Sept 11, 2006
18 September 2006
Takeda's Actos reduces risk of recurrent stroke
11 September 2006
Japan stock market week to Aug 7, 2006
14 August 2006
EC approves Takeda's antidiabetic Competact
14 August 2006
Takeda's sales reach $2.9B for 1st-qtr 2007
14 August 2006
Japan stock market week to July 31, 2006
7 August 2006
Japan stock market week to June 26, 2006
3 July 2006
Japan stock market week to June 19, 2006
26 June 2006
Japan stock market week to June 12, 2006
19 June 2006
Development of B-MS' Pargluva discontinued
29 May 2006
Japan stock market week to May 15, 2006
22 May 2006
Takeda's 2005/6 income reaches 313.2B yen
22 May 2006
Global diabetes drug market worth $15B in 2005
22 May 2006
Japan stock market week to April 24, 2006
1 May 2006
Japan stock market week to April 17, 2006
24 April 2006
Takeda 's income rises 14.4% in 1st 3 fiscal qtrs
20 February 2006
Japan stock market week to Feb 6, 2006
13 February 2006
Japan stock market week to Sept 12
19 September 2005
Stock Commentary - Tokyo week to Sept 5
12 September 2005
Japan stock market week to September 5
12 September 2005
Takeda's 1st-qtr stronger-than-expected due to volume growth
15 August 2005
NZ Pharmac gets budget boost, OKs new Rx uses
8 August 2005
Japan stock market week to July 4
11 July 2005
Japan stock market week to June 20
27 June 2005
Add-on benefits of Actos shown in study
20 June 2005
Japan stock market week to June 10
20 June 2005
B-M Squibb/Merck & Co's Pargluva: good PhI/II
20 June 2005
Japan stock market week to May 16
23 May 2005
Strong 3rd-qtr for Takeda, as Actos and candesartan expand globally
21 February 2005
Japan stock market week to February 7
14 February 2005
Tokyo pharma stocks - week to November 8
15 November 2004
Takeda's Actoplus Met filed in USA
8 November 2004
Tokyo pharma stocks - week to july 12
19 July 2004
Indian firms pay high cost for generics
12 July 2004
Tokyo pharma stocks - week to june 28
5 July 2004
Piolgitazone cuts BP in type 2 diabetics
14 June 2004
Tokyo pharma stocks - week to May 24
31 May 2004
Tokyo pharma stocks - week to April 26
3 May 2004
Takeda and Oxford University open diabetes R&D unit
23 February 2004
Stock Commentary - Europe
19 January 2004
Tokyo pharma stocks - week to Jan 12
19 January 2004
Andrx and Takeda in diabetes deal
19 January 2004
Tokyo pharma stocks - week to Dec 15
22 December 2003
Tokyo pharma stocks - week to Nov 10
17 November 2003
Tokyo pharma stocks - week to Sept 29
3 November 2003
Stock Commentary - Tokyo
27 October 2003
Takeda files lawsuits against generic firms
27 October 2003
Tokyo pharma stocks - week to Oct 20
27 October 2003
Stock Commentary - Tokyo
15 September 2003
Tokyo pharma stocks - week to Sept 8
15 September 2003
Takeda/Lilly's Actos OKed in EU as diabetes monotherapy
8 September 2003
Tokyo pharma stocks - week to July 28
4 August 2003
Riken subscribes to Inpharmatica's Biopendium
28 July 2003
Tokyo pharma stocks - week to June 16
23 June 2003
Tokyo stocks to April 28
5 May 2003
Takeda forecasts 315B yen profit in 2004
28 April 2003
Underlying growth beats forecasts at Lilly
28 April 2003
GSK's Avandia cleared for use with insulin
10 March 2003
Tularik to commence diabetes study
3 February 2003
Tokyo pharma stocks - week to Jan 27
3 February 2003
Robust Takeda faces growing competition
13 January 2003
Analysts see threat to Novartis' Lotrel
6 January 2003
Tokyo pharma stocks - week to July 29
5 August 2002
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
